🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System (ANS) Functions in Children and Adolescents With ADHD

Recruitingn/aAges 6 Years - 17 YearsAllUmeå University
NCT07634809 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An increasing number of children are being diagnosed with ADHD, and the demand for ADHD medication has been rising. Although ADHD medication is often effective, this is unfortunately not the case for all children and adolescents with ADHD; furthermore, the majority of those who use the medication experience side effects of some kind. There are currently no known factors that are clearly linked to whether ADHD medications will be effective or cause significant side effects. The healthcare system therefore has limited ability to provide recommendations on ADHD medication at the individual level, which means that most children and adolescents with ADHD try medication. Studies show that 35% of children aged 4-11 and 53% of 12-17-year-olds discontinue ADHD medication within a year. Perhaps these children and adolescents could have avoided fruitless treatment attempts if the healthcare system

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * ages of 6 -17 * diagnosis of ADHD and agreed to medication administration in accordance with the clinic's procedures. Exclusion Criteria: * diagnoses of arrhythmia, cardiovascular disease, or current substance use * concurrent use of non-steroidal asthma medications or beta-blockers * the inability to complete study participation before the participant's 18th birthday. * severe motor impairments and visual impairments that prevent participation in eye-tracking measurements. * caffeine intake within 4 hours prior to HRV and eye-tracking measurements
💊

What it tests

  • metylphenidate
📍

Where

1 site
BUP Umeå
Umeå, Sweden
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy